logo

For the Inventor, By the Inventor

Rensselaer, NY, United States of America

Nanopharmaceuticals LLC


USPTO Granted Patents = 21

% Expired Patents = 42.9



Forward Citations = 170

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Shaker Ahmed Mousa (21 out of 81 patents)

silverMedal Paul J Davis (13 out of 18 patents)

bronzeMedal Faith B Davis (6 out of 11 patents)

4.  Mehdi Rajabi (5 out of 5 patents)

5.  Ozlem O Karakus (4 out of 4 patents)

6.  Bruce Allan Hay (3 out of 27 patents)

7.  Maria Alexander-Bridges (1 out of 1 patent)

8.  Gennadi V Glinksy (1 out of 1 patent)

9.  Aleck Hercbergs (1 out of 1 patent)

10.  Hung-Yun Lin (1 out of 2 patents)

11.  Gennadi V Glinsky (1 patent)

12.  Shaker A Mousa (2 patents)


21 patents:

1. 11723888 - Polymer conjugated thyrointegrin antagonists (2023-08-15),
2. 11351137 - Composition and method for dual targeting in treatment of neuroendocrine tumors (2022-06-07),
3. 11186551 - Composition of scalable thyrointegrin antagonists with improved retention in tumors (2021-11-30),
4. 11077082 - Composition and method for dual targeting in treatment of neuroendocrine tumors (2021-08-03),
5. 10961204 - Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors (2021-03-30),
6. 10695436 - Non-cleavable polymer conjugated with alpha V beta 3 integrin thyroid antagonists (2020-06-30),
7. 10328043 - Composition and method for dual targeting in treatment of neuroendocrine tumors (2019-06-25),
8. 10201616 - Non-cleavable polymer conjugated with αVβ3 integrin thyroid antagonists (2019-02-12),
9. 10130686 - Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders (2018-11-20),
10. 10060934 - Methods for screening patients for resistance to angioinhibition, treatment and prophylaxis thereof (2018-08-28),
11. 9980933 - Thyroid hormone analogs and methods of use (2018-05-29),
12. 9839614 - Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof (2017-12-12),
13. 9750709 - Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof (2017-09-05),
14. 9579300 - Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof (2017-02-28),
15. 9498536 - Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders (2016-11-22),
Nanopharmaceuticals LLC, based in Rensselaer, NY, specializes in the development and manufacturing of innovative pharmaceutical products utilizing nanotechnology. The company focuses on enhancing drug delivery systems to improve therapeutic efficacy and patient outcomes. By leveraging advanced research in nanomedicine, Nanopharmaceuticals aims to address complex medical challenges and contribute to the evolution of targeted therapies. Their expertise encompasses a range of applications within the pharmaceutical industry, emphasizing precision and effectiveness.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

21 Patents

#1 in Rensselaer, NY

#920 in New York

#15,668 in US

#29,893 in the World

Rensselaer, NY (US)
Rensselaer, NY, United States of America

Nanopharmaceuticals LLC

Forward Citations = 170

10 inventors:

goldMedal Shaker Ahmed Mousa (21 out of 81 patents)

silverMedal Paul J Davis (13 out of 18 patents)

bronzeMedal Faith B Davis (6 out of 11 patents)

4.  Mehdi Rajabi (5 out of 5 patents)

5.  Ozlem O Karakus (4 out of 4 patents)

Please report any incorrect information to [email protected]
Loading…